Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
7/18/2022
NHC's 2021 Annual Health Sector Development Report (Full Summary)
7/18/2022
How China's Big Pharma Bet Could Change Intellectual Property Game
7/15/2022
China's Community Health Centers Are Losing Public Appeal
7/15/2022
Chinese Leaders Pledge to Advance Reform and Reduce Public Healthca...
7/15/2022
Recent Official and Executive Moves
7/14/2022
CStone Considers Sale Amid Mounting Challenges: Bloomberg
7/14/2022
China's Latest Round of Volume-Based Procurement of Drugs Further Redu...
7/14/2022
Chinese Biopharma In-licensing Deals in H1/2022 (Pharmcube)
7/14/2022
China's Budding Drug Innovation Shows Signs of Life Despite Biotech Wi...
7/13/2022
Chinese Drugmakers Set Sights on Emerging Markets (PharmaDJ)
7/13/2022
Chinese Biopharma Out-licensing Deals in H1/2022 (Pharmcube)
7/12/2022
AstraZeneca, Pfizer, Novartis and More Lose Out in China's Latest Roun...
7/12/2022
Youtube Video: Layoff Triggered in China's Pharma as Beijing Continues...
7/12/2022
JPO Publicizes 7th VBP Tender Outcome, Which Slashes Average Prices by...
7/11/2022
NMPA Announces OTC Switch of Potassium Glucosamine Sulfate Tablets
7/11/2022
Tasly Pharma and Mauna Kea Tech Announce JV and Licensing Pact
7/8/2022
Chinese Government Issues New Document to Secure Urban/Rural Resident ...
7/8/2022
Sinopharm Explores $1 Billion Deal for BBI Life Sciences
7/7/2022
Pharmaron Acquires Commercial API Manufacturing Facility in the U.S.
7/6/2022
Illumina and Sequoia Capital Launch Genomics Startup Incubator in Chin...
7/5/2022
Biotech Winter in China Set to Adjust Valuation and Prompt Consolidati...
7/1/2022
PharmaDJ: MSD and Turning Point Turn to China for Big Deals in May
7/1/2022
PhIIC: Representative Hospital Drug Sales Nears CNY 60B in Q1/2022
7/1/2022
Recent Executive Moves
7/1/2022
Solasia to Slash 65% of Workforce in China as It Transfers Core Distri...
6/29/2022
WuXi STA Opens Another High-Potency API Plant In Changzhou
6/29/2022
NMPA Issues the Implementation Plans for Manufacture by Hong Kong and ...
6/29/2022
Nature: Unleashing the Power of Big Data to Guide Precision Medicine i...
6/28/2022
NMPA Issues Notice to Further Strengthen Services to Foreign-Invested ...
6/28/2022
BioLineRx and GenFleet Agree to Further Develop Motixafortide in PDAC...
Page:
41
/
333
Total number of articles:
9989
:
[First]
[<<]
[39]
[40]
[41]
[42]
[43]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit